Geri
NervGen Pharma Corp. (NGENF) Fiyatı
NGENF Hisse Senedi Fiyat Grafiği
NGENF Fiyat
NervGen Pharma Corp.
$5.07
-2.87%
$-0.14
Bugün itibarıyla:Jan 26, 12:01:28 GMT-5
Önemli İstatistikler
Önceki Kapanış
$5.22
Açılış fiyatı
$5.17
Günün Aralığı
$4.8 - $5.23
52 haftalık aralık
$1.5 - $6.3
İşlem hacmi
132.7K
Ort.Hacim
141.6K
EPS (TTM)
-0.26
Dividend yield
--
Piyasa Değeri
$401.6M
NervGen Pharma Corp. nedir?
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved
